Jones Financial Companies
COLL icon

Jones Financial Companies’s Collegium Pharmaceutical COLL Stock Holding History

Jones Financial Companies’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.6K Buy
1,081
+912
+540% +$31.2K ﹤0.01% 3222
2026
Q1 		$5.48K Buy
169
+162
+2,314% +$6.86K ﹤0.01% 3795
2025
Q4 		$324 Hold
7
– – ﹤0.01% 4222
2025
Q3 		$241 Hold
7
– – ﹤0.01% 4113
2025
Q2 		$210 Buy
+7
New +$200 ﹤0.01% 3910
2025
Q1 		– Sell
-4
Closed -$115 – 3739
2024
Q4 		$115 Buy
+4
New +$132 ﹤0.01% 3344

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Jones Financial Companies's COLL Position: Q2 2026 in Review

Jones Financial Companies increased its Collegium Pharmaceutical (COLL) stake by 540% in Q2 2026, buying an estimated $31.2K and bringing the position to 1,081 shares worth $39.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3222.

Jones Financial Companies first reported a position in COLL in Q4 2024 and has held it in 6 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Jones Financial Companies held 1,081 shares of Collegium Pharmaceutical worth $39.6K as of Q2 2026.
  • Jones Financial Companies bought 912 Collegium Pharmaceutical shares in Q2 2026, an estimated $31.2K.
  • Collegium Pharmaceutical made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3222 holding.
  • Jones Financial Companies first reported a position in Collegium Pharmaceutical in Q4 2024 and has held it in 6 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.